Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, and the world leader in diabetes care. The company also develops treatments for obesity, rare blood disorders, and growth-hormone therapy, including its widely known GLP-1 medicines Ozempic, Wegovy, and Rybelsus. - View it on GitHub